Zobrazeno 1 - 10
of 220
pro vyhledávání: '"Daniel A. Pryma"'
Autor:
Hwan Lee, Sarit T. Kipnis, Remy Niman, Sophia R. O’Brien, Jennifer R. Eads, Bryson W. Katona, Daniel A. Pryma
Publikováno v:
Cancers, Vol 16, Iss 1, p 200 (2023)
Background: Treatment of metastatic neuroendocrine tumors (NET) with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) results in favorable response only in a subset of patients. We investigated the prognostic value of quantitative pre-trea
Externí odkaz:
https://doaj.org/article/3926c418379e49cb833ab90ce34f0bc7
Autor:
Mehran Makvandi, Minu Samanta, Paul Martorano, Hwan Lee, Sarah B. Gitto, Khushbu Patel, David Groff, Jennifer Pogoriler, Daniel Martinez, Aladdin Riad, Hannah Dabagian, Michael Zaleski, Tara Taghvaee, Kuiying Xu, Ji Youn Lee, Catherine Hou, Alvin Farrel, Vandana Batra, Sean D. Carlin, Daniel J. Powell, Robert H. Mach, Daniel A. Pryma, John M. Maris
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-9 (2022)
The efficacy and toxicity of the PARP inhibitor parthanatine, radiolabeled with the alpha particle emitter astatine-211, in 11 patient derived neuroblastoma murine xenografts is investigated.
Externí odkaz:
https://doaj.org/article/39307010894b498daf099e0526685b72
Autor:
José Marcio Luna, Hann-Hsiang Chao, Russel T. Shinohara, Lyle H. Ungar, Keith A. Cengel, Daniel A. Pryma, Chidambaram Chinniah, Abigail T. Berman, Sharyn I. Katz, Despina Kontos, Charles B. Simone, II, Eric S. Diffenderfer
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss , Pp 69-75 (2020)
Background and Purpose: Radiation esophagitis is a clinically important toxicity seen with treatment for locally-advanced non-small cell lung cancer. There is considerable disagreement among prior studies in identifying predictors of radiation esopha
Externí odkaz:
https://doaj.org/article/4f9a3c1e3a2d4d608c79d2cf6344e73b
Autor:
Elizabeth S. McDonald, Austin R. Pantel, Payal D. Shah, Michael D. Farwell, Amy S. Clark, Robert K. Doot, Daniel A. Pryma, Sean D. Carlin
Publikováno v:
JCI Insight, Vol 6, Iss 8 (2021)
BACKGROUND [18F]FluorThanatrace ([18F]FTT) is a radiolabeled poly (adenosine diphosphate-ribose) polymerase inhibitor (PARPi) that enables noninvasive quantification of PARP with potential to serve as a biomarker for patient selection for PARPi thera
Externí odkaz:
https://doaj.org/article/d6ab613d6d334089b95b77f1f24d6e3c
Autor:
Amit Maity, Rosemarie Mick, Ramesh Rengan, Tara C. Mitchell, Ravi K. Amaravadi, Lynn M. Schuchter, Daniel A. Pryma, Dana M. Patsch, Alisha P. Maity, Andy J. Minn, Robert H. Vonderheide, John N. Lukens
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
We conducted a phase I dose-escalation trial of radiation with ipilimumab in patients with melanoma with ≥2 metastatic lesions. Here, we report the final full clinical analysis. Patients received RT (6 or 8 Gy x 2 or 3 doses) to a single lesion fol
Externí odkaz:
https://doaj.org/article/095b996398624a97bbe6f7d9f1fa3de8
Autor:
Marina Cuchel, Anna C. Raper, Donna M. Conlon, Daniel A. Pryma, Richard H. Freifelder, Rahul Poria, Debra Cromley, Xiaoyu Li, Richard L. Dunbar, Benjamin French, Liming Qu, William Farver, Ching-Chiang Su, Sissel Lund-Katz, Amanda Baer, Giacomo Ruotolo, Peter Akerblad, Carol S. Ryan, Lan Xiao, Todd G. Kirchgessner, John S. Millar, Jeffrey T. Billheimer, Daniel J. Rader
Publikováno v:
Journal of Lipid Research, Vol 58, Iss 4, Pp 752-762 (2017)
Reverse cholesterol transport (RCT) is thought to be an atheroprotective function of HDL, and macrophage-specific RCT in mice is inversely associated with atherosclerosis. We developed a novel method using 3H-cholesterol nanoparticles to selectively
Externí odkaz:
https://doaj.org/article/50852041bbb149b0ab71cadc9ddee278
Autor:
Daniel A. Pryma
In contrast to most anatomic radiographic imaging techniques, nuclear medicine permits real time, non-invasive imaging of human physiology and pathophysiology and also allows for exquisite targeting of disease with therapeutic radiology. To open this
Autor:
Sara P. Ginzberg, Jacqueline M. Soegaard Ballester, Christopher J. Wirtalla, Knashawn H. Morales, Daniel A. Pryma, Susan J. Mandel, Rachel R. Kelz, Heather Wachtel
Publikováno v:
Annals of Surgical Oncology. 30:2928-2937
Autor:
Stefaan Vandenberghe, Nicolas A. Karakatsanis, Maya Abi Akl, Jens Maebe, Suleman Surti, Rudi A. Dierckx, Daniel A. Pryma, Sadek A. Nehmeh, Othmane Bouhali, Joel S. Karp
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 50. SPRINGER
Purpose: Total body positron emission tomography (TB-PET) has recently been introduced in nuclear medicine departments. There is a large interest in these systems, but for many centers, the high acquisition cost makes it very difficult to justify the
Autor:
Stephen E. Moore, Jennifer R. Eads, Carina Mari Aparici, Hwan Lee, Ryusuke Nakamoto, Daniel A. Pryma, Austin R. Pantel
Publikováno v:
Academic Radiology. 29:1308-1316
Rationale and Objectives High-grade gastroenteropancreatic neuroendocrine neoplasms (G3 GEP-NENs) are pathologically classified into well differentiated neuroendocrine tumors (G3 NETs) and poorly differentiated neuroendocrine carcinomas (G3 NECs). Us